TIAA-CREF Investment Management »

Takeda Pharmaceutical shares owned by TIAA-CREF Investment Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by TIAA-CREF Investment Management from 13F filings

Historical chart of TIAA-CREF Investment Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by TIAA-CREF Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by TIAA-CREF Investment Management

Quarter filed Position value Share count Share price at filing
2019-03-31 $134M 6.6M 20.37

More positions owned by TIAA-CREF Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class C cs (GOOG)
Facebook Inc cl a (META)
Visa (V)
Alphabet Inc Class A cs (GOOGL)
salesforce (CRM)
MasterCard Incorporated (MA)
Johnson & Johnson (JNJ)
Cisco Systems (CSCO)
Paypal Holdings (PYPL)
Merck & Co (MRK)
Procter & Gamble Company (PG)
Berkshire Hathaway (BRK.B)

View all positions for TIAA-CREF Investment Management

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Millennium Management
Brandes Investment Partners
Renaissance Technologies
First Trust Advisors
FMR
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management

View all funds holding Takeda Pharmaceutical